November 2013
-
Story Access to Healthcare
Telemedicine: Taking health care to the world's far corners
Ann Aerts has stared death in the eye. The head of the non-profit Novartis Foundation lost colleagues when she was serving as an emergency medicine physician on a medical mission in a dangerously unstable country.
-
Story Access to Healthcare
Fighting malaria in Africa
The head of Public Affairs for the Novartis Malaria Initiative has a malaria story of her own to tell.
October 2013
-
Story From Our Labs
Young talent & emerging technologies come together at BioCamp
University students majoring in the life sciences or business often have trouble imagining the direction of their careers.
-
Story Patient Perspectives
Protecting our tomorrows: Portraits of Meningococcal Disease
To raise awareness of the sudden and profound impact of meningococcal disease on families across the globe, world-renowned photographer Anne Geddes has joined forces with the Confederation of Meningitis Organizations (CoMO) and Novartis Vaccines and Diagnostics for the Protecting Our Tomorrows: Portraits of Meningococcal Disease project.
-
Story From Our Labs
Disease pathways: A key to new drug discovery
Using new technologies, researchers have developed a deeper understanding of how cells function, changing conceptions of disease.
-
Story Discovery
Tackling a rare disease: Working toward a treatment for SMA
Most people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.
-
Story Access to Healthcare
Making healthcare sustainable in the developing world
Today, many companies are trying to solve global health challenges through philanthropy. However, it has become clear that philanthropy alone is no longer enough to make a lasting impact.
-
Story From Our Labs
Surfing the wave of big data analytics
The cause of a rare, inherited, often fatal kidney disease in many patients remained elusive for years, despite multiple attempts to solve the mystery. Then in 2012, a team of researchers cracked some of the unsolved cases in just six weeks.
